Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety

Conference contribution


Publication Details

Author(s): Schlichtig K, Duerr P, Dörje F, Fromm F
Publisher: SPRINGER HEIDELBERG
Publishing place: HEIDELBERG
Publication year: 2019
Conference Proceedings Title: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Pages range: S18-S18
ISSN: 0031-6970


FAU Authors / FAU Editors

Dörje, Frank Prof. Dr.
Professur für Molekulare und Klinische Pharmazie
Schlichtig, Katja
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie


How to cite

APA:
Schlichtig, K., Duerr, P., Dörje, F., & Fromm, F. (2019). Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (pp. S18-S18). Stockholm, SE: HEIDELBERG: SPRINGER HEIDELBERG.

MLA:
Schlichtig, Katja, et al. "Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety." Proceedings of the 14th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics (EACPT), Stockholm HEIDELBERG: SPRINGER HEIDELBERG, 2019. S18-S18.

BibTeX: 

Last updated on 2019-16-07 at 13:23